Hesperidin acts as an anti-cancer agent by promoting apoptosis in malignant cells such as liver cancer and bladder cancer cells via NF-κB, MAPK, and PI3K/AKT pathways. This evidence concerns the gene NFKB1 and urinary bladder cancer.